IFS Surges Ahead in H1 2025: 30% ARR Growth and Breakthrough Agentic AI Cement Industrial Leadership
LONDON, July 23, 2025 /PRNewswire/ -- IFS, the leading provider of enterprise cloud and Industrial AI software, today announced record-setting H1 2025 results. The company is rewriting the rules of enterprise software with Industrial AI that acts, learns, and delivers. In H1, IFS outpaced legacy enterprise vendors, driving double-digit growth across all key performance metrics, further validating the strength of IFS's strategy, the scalability of its model, and accelerating momentum as the category leader in Industrial AI.
IFS H1 2025 Key Financial Results:
Annual Recurring Revenue (ARR): +30% YoY
Cloud Revenue: +37% YoY
Recurring Revenue: +24% YoY (now 82% of total revenue)
Unlike traditional, legacy software vendors, IFS is purpose-built for the operational core of industrial businesses, powering the real-world systems that keep the world running. Average customer deal size from new customers continued to grow significantly in the first half of the year, with 130 leading industrial brands choosing to future-proof their growth with IFS in H1, including: Arcelor Mittal, Callaway, Collins Aerospace, Hitachi Energy, Japan Airlines, TotalEnergies.
In addition to continued organic growth, IFS extended its Industrial AI lead with the acquisition of TheLoops, launching the first agentic AI workforce for complex industries. Complementing this, the launch of Nexus Black, IFS's AI innovation accelerator, is already delivering bespoke, scalable solutions that traditional platforms cannot match.
Together, Nexus Black and TheLoops mark a new era for enterprise software, where self-learning AI agents operate in real time inside customer environments, reducing manual effort and accelerating decisions from edge to boardroom.
"Our phenomenal growth proves customers are done with AI theory. They want AI that solves real problems, at scale, and are placing their trust in IFS to lead them through the Industrial AI revolution," said Mark Moffat, CEO of IFS. "The connection between our performance and AI innovation is unmistakable. As demand intensifies, IFS stands apart, thanks to our domain depth, contextual intelligence, and unwavering focus on industry."
Matthias Heiden, CFO of IFS commented: "Our fiscal performance reflects the fast-growth, differentiated Industrial AI leader that IFS has become, with a disciplined financial model rooted in recurring revenue, resilient operations, and scale-ready agility. These same principles are built into our solutions to empower our customers to drive long-term value. With this strong foundation, we're not just growing, we're redefining what's possible for industrial enterprises."
Demand for AI-powered solutions from prior acquisitions – Copperleaf, Poka, Ultimo, P2 and EmpowerMX – remains strong and continues to contribute meaningfully to IFS's growth. IFS's thriving global network of strategic partners also played a key role in enabling continued scaling and deal size growth.
H1 Highlights:
AI and Innovation
Launched Nexus Black: bespoke accelerator for industrial-grade scalability and security
Acquired TheLoops: first agentic AI workforce for mission-critical industries
Released IFS Cloud 25R1: made 200+ AI-driven capabilities
Market Momentum and Recognition
EUR 15 billion valuation amid soaring Industrial AI demand
Only company named Customers' Choice in the 2025 Gartner Peer Insights Voice of the Customer for EAM report
IFS ranked #1 for EAM for fourth consecutive year, Gartner Market Share: Enterprise Software, Worldwide, 2024 report
Named a Leader in two IDC MarketScape 2024-2025 Vendor Assessments in two IDC MarketScape 2024-2025 Vendor Assessments
IFS appointed Advisor to UK Parliamentary Group on AI
IFS Press Contacts:EUROPE / MEA / APJ: Adam GillbeIFS, Director of Corporate & Executive CommunicationsEmail: adam.gillbe@ifs.com
NORTH AMERICA / LATAM: Mairi MorganIFS, Director of Corporate & Executive CommunicationsEmail: mairi.morgan@ifs.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
https://mb.cision.com/Public/855/4210323/999f50a879e84404_org.jpg
IFS Image H1-2025-Earnings-Web 07 25-01 1
View original content:https://www.prnewswire.com/apac/news-releases/ifs-surges-ahead-in-h1-2025-30-arr-growth-and-breakthrough-agentic-ai-cement-industrial-leadership-302511826.html
SOURCE IFS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
JD.com Announces Decision to Make a Voluntary Public Takeover Offer and Strategic Investment Partnership with CECONOMY
BEIJING, July 30, 2025 (GLOBE NEWSWIRE) -- Inc. (' or the 'Company') (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it decided to make a voluntary public takeover offer, through a wholly-owned indirect subsidiary JINGDONG Holding Germany GmbH (the 'Bidder'), to all shareholders of CECONOMY AG ('CECONOMY') (XETRA: CEC), the parent company of leading European consumer electronics retailers MediaMarkt and Saturn, to acquire all issued and outstanding bearer shares in CECONOMY (the 'CECONOMY Shares') for a cash consideration of EUR 4.60 per share (the 'Takeover Offer'). The Bidder and CECONOMY have also signed an investment agreement regarding the Takeover Offer and their intended cooperation after completion of the Takeover Offer. Furthermore, regarding their future cooperation, the Bidder and CECONOMY's largest shareholder group comprising Convergenta Invest GmbH and related shareholders (together, 'Convergenta') entered into a shareholders' agreement, effectiveness of which is subject to the completion of the Takeover Offer. As a result, post the completion of the Takeover Offer, Convergenta will hold 25.35% of the CECONOMY Shares, reducing its current shareholding in CECONOMY from 29.16% by an irrevocable undertaking to accept the Takeover Offer with respect to 3.81% of the CECONOMY Shares. The Bidder has also entered into agreements with several shareholders of CECONOMY, under which those shareholders have irrevocably undertaken to accept the Takeover Offer with respect to 31.7% of the CECONOMY Shares in total (including 3.81% from Convergenta), securing a total shareholding of 57.1% in combination with the retained stake of future partner Convergenta ahead of the launch of the Takeover Offer. CECONOMY is a European retail leader in the field of consumer electronics. Its main brands MediaMarkt and Saturn operate omni-channel retail businesses, combining strong e-commerce presence with more than 1,000 retail stores in 11 countries. Under the strategic investment agreement, the Company and CECONOMY aim to drive CECONOMY's growth as a stand-alone business and accelerate CECONOMY's transformation into Europe's leading omni-channel consumer electronics platform. renowned for its superior customer experience and industry-leading e-commerce logistics service standards, will contribute its advanced technology, leading omni-channel retail expertise, and logistics and warehouse capabilities to the partnership. This will strengthen CECONOMY's capabilities and further develop its core business and capitalize on its market position. As part of the strategic roadmap, CECONOMY will remain a stand-alone business in Europe with a local independent technology stack, and no changes are planned to the workforce, employee agreements and sites. CECONOMY's Supervisory Board and Management Board fully support the public Takeover Offer. 'This partnership with CECONOMY will build Europe's leading next-generation consumer electronics platform,' said CEO Sandy Xu. 'CECONOMY's market-leading position, strong customer relationships and growth are impressive, and we are firmly committed to investing in its people and distinct culture to build on this success. We will work with the team to strengthen the capabilities, while applying our advanced technology capabilities to accelerate CECONOMY's ongoing transformation. Our goal is to further grow CECONOMY's platform across Europe and create long-term value for customers, employees, investors and local communities. We have full confidence in the management team of CECONOMY and look forward to working together to initiate the next phase of growth.' CECONOMY CEO Dr. Kai-Ulrich Deissner said, 'With outstanding retail, logistics, and technology capabilities, we can further accelerate our successful growth trajectory and go beyond our current strategic goals. Thanks to the tremendous dedication and commitment of our entire team, CECONOMY operates from a position of strength. Given the constantly evolving customer expectations and market dynamics, standing still is not an option. In the coming years, we don't just want to keep pace with the transformation in European retail – we want to continue leading it. is the right partner for this. We share a passion for our customers and a firm belief that our employees, trusted partnerships with international brand manufacturers, and the combination of digital and brick-and-mortar business are the keys to success. We partner with to strengthen European retail, based on complementary strengths and shared values.' 'We fully support the strategic investment agreement and takeover offer and are confident that it represents the best opportunity to further drive the successful transformation of CECONOMY,' said Jürgen Kellerhals of anchor shareholder Convergenta. 'The management team of CECONOMY has a clear strategic vision, and brings the resources and expertise required to accelerate the company's (CECONOMY's) next phase of growth. The technological expertise of is world-leading, as demonstrated by its success in other markets. As the long-term anchor investor, we believe this is the right step at the right time for the business, our employees, and our customers.' The Takeover Offer will be subject to customary conditions, including, among others, merger control, foreign direct investment and foreign subsidies clearances. The Takeover Offer will not be subject to a minimum acceptance rate. The transaction will be financed through a combination of acquisition loan and the Company's cash on balance sheet. The closing of the Takeover Offer is expected to take place in the first half of 2026. The Offer Document (in German and a non-binding English translation) which will set forth the detailed terms and conditions of the Takeover Offer, as well as further information relating thereto, will be published by the Bidder following approval by the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht) on the internet at the website This announcement and the information within it are not intended to, and do not, constitute or form part of any offer to purchase or a solicitation of an offer to sell the CECONOMY Shares. Investors and holders of CECONOMY Shares are strongly advised to read the Offer Document and all other documents relating to the Takeover Offer as soon as they have been made public, as they will contain important information. About Inc. is a leading supply chain-based technology and service provider. The Company's cutting-edge retail infrastructure seeks to enable consumers to buy whatever they want, whenever and wherever they want it. The Company has opened its technology and infrastructure to partners, brands and other sectors, as part of its Retail as a Service offering to help drive productivity and innovation across a range of industries. Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the 'safe harbor' provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'will,' 'expects,' 'anticipates,' 'future,' 'intends,' 'plans,' 'believes,' 'estimates,' 'confident' and similar statements. may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the 'SEC'), in announcements made on the website of the Hong Kong Stock Exchange, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: growth strategies; its future business development, results of operations and financial condition; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; trends and competition in China's e-commerce market; changes in its revenues and certain cost or expense items; the expected growth of the Chinese e-commerce market; laws, regulations and governmental policies relating to the industries in which or its business partners operate; potential changes in laws, regulations and governmental policies or changes in the interpretation and implementation of laws, regulations and governmental policies that could adversely affect the industries in which or its business partners operate, including, among others, initiatives to enhance supervision of companies listed on an overseas exchange and tighten scrutiny over data privacy and data security; risks associated with acquisitions, investments and alliances, including fluctuation in the market value of investment portfolio; natural disasters and geopolitical events; change in tax rates and financial risks; intensity of competition; and general market and economic conditions in China and globally. Further information regarding these and other risks is included in filings with the SEC and the announcements on the website of the Hong Kong Stock Exchange. All information provided herein is as of the date of this announcement, and undertakes no obligation to update any forward-looking statement, except as required under applicable law. For investor and media inquiries, please contact: Investor RelationsSean Zhang+86 (10) 8912-6804IR@ Media Relations+86 (10) 8911-6155Press@ in to access your portfolio
Yahoo
an hour ago
- Yahoo
Official – Sevilla Buy Further 40% Of France Midfielder Rights: Inter Milan Still Own 10%
La Liga giants Sevilla have acquired an additional 40% of Lucien Agoume, increasing their total ownership of the former Inter Milan midfielder. According to the club's official website, Los Nervionenses have paid €4 million to secure the extra portion of his rights. Following several underwhelming loan spells, Lucien Agoume swapped San Siro for Seville last summer. However, the Spaniards purchased only half of his rights at the time, agreeing to a co-ownership deal with the Nerazzurri. Sevilla Purchase Another 40% of Lucien Agoume Rights from Inter Milan LA SPEZIA, ITALY – MAY 23: Lucien Agoume of Spezia Calcio in action during the Serie A match between Spezia Calcio and AS Roma at Stadio Alberto Picco on May 23, 2021 in La Spezia, Italy. (Photo by) The Andalusian powerhouse held only half of Agoume's rights throughout the 2024/25 season. Yet, the 23-year-old has convinced the ex-Europa League winners to increase their stake by purchasing an additional 40%. Indeed, the Frenchman had an impressive season at Estadio Ramon Sanchez Pizjuan in 2024/25. He racked up 35 appearances in La Liga, netting one goal and providing three assists. Therefore, Sevilla's decision to increase their stake in the ownership comes as no surprise. Meanwhile, Inter can reinvest the money in the transfer market.
Yahoo
an hour ago
- Yahoo
Formycon Invites to Conference Call on 2025 Half-year Results and Announces Participation in International Investor Conferences in the 3rd Quarter of 2025
PLANEGG-MARTINSRIED, Germany - July 30, 2025 (NEWMEDIAWIRE) - Formycon AG (FSB: FYB, Prime Standard, Formycon") plans to publish its results of the first half of the 2025 fiscal year on August 13, 2025. The Management Board will discuss the company's development, key financial figures, and provide an outlook for the course of 2025. The conference call, which will be broadcast live on the internet, will take place on Wednesday, August 13, 2025, at 3:00 PM (CEST) in English. To participate in the conference call, please register at: After registration, participants will receive a confirmation email with individual dial-in data. The presentation and audio broadcast can be accessed via the following webcast link: After a brief presentation, the Management Board will be available for analysts' questions. The conference call will be recorded and can subsequently be accessed via the Formycon website at: Formycon in Dialogue Representatives of the Management Board will participate in the following international investor conferences in the third quarter of 2025: August 28, 2025HIT Hamburg Investors' DayEnno Spillner (CFO)Hamburg September 03 05, 20252025 Wells Fargo Healthcare ConferenceEnno Spillner (CFO)Everett / Boston September 08 10, 2025H.C. Wainwright 27th Annual Global Investment ConferenceEnno Spillner (CFO)New York City September 23, 2025Berenberg & Goldman Sachs German Corporate ConferenceDr. Stefan Glombitza (CEO), Enno Spillner (CFO)Munich Additionally scheduled conference participations in 2025: November 17 20, 2025Jefferies Global Healthcare ConferenceEnno Spillner (CFO)London November 24 26, 2025Deutsche Borse Equity ForumEnno Spillner (CFO)Frankfurt Please find our current events at: About Formycon:Formycon AG (FSE: FYB) is a leading, independent developer of high-quality biosimilars, follow-on products of biopharmaceutical medicines. The company focuses on therapies in ophthalmology, immunology, immuno-oncology and other key disease areas, covering almost the entire value chain from technical development through clinical trials to approval by the regulatory authorities. For commercialization of its biosimilars, Formycon relies on strong, well-trusted and long-term partnerships worldwide. With FYB201/ranibizumab and FYB202/ustekinumab, Formycon already has two biosimilars on the market in Europe and the USA. A third biosimilar, FYB203/aflibercept, has been approved by the FDA, EMA, and MHRA; FYB202 is also approved in Canada. Another four biosimilar candidates are currently in development. With its biosimilars, Formycon is making an important contribution to providing as many patients as possible with access to highly effective and affordable medicines. Formycon AG is headquartered in Munich, listed in the Prime Standard of the Frankfurt Stock Exchange: FYB / ISIN: DE000A1EWVY8 / WKN: A1EWVY and is part of the SDAX and TecDAX selection indices. Further information can be found at: About Biosimilars:Since their introduction in the 1980s, biopharmaceutical drugs have revolutionized the treatment of serious and chronic diseases. By 2032, many of these drugs will lose their patent protection - including 45 blockbusters with an estimated total annual global turnover of more than 200 billion US dollars. Biosimilars are successor products to biopharmaceutical drugs for which market exclusivity has expired. They are approved in highly regulated markets such as the EU, the USA, Canada, Japan and Australia in accordance with strict regulatory procedures. Biosimilars create competition and thus give more patients access to biopharmaceutical therapies. At the same time, they reduce costs for healthcare systems. Global sales of biosimilars currently amount to around 21 billion US dollars. Analysts assume that sales could rise to over 74 billion US dollars by 2030. Contact:Sabrina MullerDirector Investor Relations & Corporate CommunicationsFormycon AGFraunhoferstr. 1582152 Planegg-MartinsriedGermany Tel.: +49 (0) 89 - 86 46 67 149Fax: + 49 (0) 89 - 86 46 67 110Mail: press release may contain forward-looking statements and information which are based on Formycon's current expectations and certain assumptions. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, performance of the company, development of the products and the estimates given here. Such known and unknown risks and uncertainties comprise, among others, the research and development, the regulatory approval process, the timing of the actions of regulatory bodies and other governmental authorities, clinical results, changes in laws and regulations, product quality, patient safety, patent litigation, contractual risks and dependencies from third parties. With respect to pipeline products, Formycon AG does not provide any representation, warranties or any other guarantees that the products will receive the necessary regulatory approvals or that they will prove to be commercially exploitable and/or successful. Formycon AG assumes no obligation to update these forward-looking statements or to correct them in case of developments which differ from those anticipated. This document neither constitutes an offer to sell nor a solicitation of an offer to buy or subscribe for securities of Formycon AG. No public offering of securities of Formycon AG will be made nor is a public offering intended. This document and the information contained therein may not be distributed in or into the United States of America, Canada, Australia, Japan or any other jurisdictions, in which such offer or such solicitation would be prohibited. This document does not constitute an offer for the sale of securities in the United States. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
